Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!
Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!
Author
Oncology Times
Published
Tue 13 Oct 2009
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/CornelisVanDeVeldePODCAST.mp3
Share to:
